−0.0003USD
−454.07 KUSD
2.73 KUSD
260.12 M
About Halberd Corp.
Sector
Industry
CEO
William A. Hartman
Website
Headquarters
Jackson Center
Founded
2009
FIGI
BBG000M2NY19
Halberd Corp. is a development stage company, which engages in the research and development of antibodies and devices for the prevention, detection, and treatment of neurodegenerative diseases. It offers patented extracorporeal treatment that is applicable to various blood-borne and neurologic diseases such as PTSD/ CTE (Post Traumatic Stress Disorder/Chronic Traumatic Encephalopathy), Alzheimer's Disease, and Parkinson's Disease. The company was founded by Mark Sven Lundquist and John Christopher Maddox on January 26, 2009 and is headquartered in Jackson Center, PA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of HALB is 0.0080 USD — it has decreased by 0.87% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Halberd Corp. stocks are traded under the ticker HALB.
HALB stock is 15.96% volatile and has beta coefficient of 0.40. Check out the list of the most volatile stocks — is Halberd Corp. there?
Yes, you can track Halberd Corp. financials in yearly and quarterly reports right on TradingView.
HALB stock has risen by 6.73% compared to the previous week, the month change is a 11.18% rise, over the last year Halberd Corp. has showed a 27.23% decrease.
HALB net income for the last quarter is −10.11 K USD, while the quarter before that showed −49.59 K USD of net income which accounts for 79.61% change. Track more Halberd Corp. financial stats to get the full picture.
Today Halberd Corp. has the market capitalization of 4.13 M, it has increased by 4.71% over the last week.
No, HALB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, HALB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Halberd Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Halberd Corp. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Halberd Corp. stock shows the sell signal. See more of Halberd Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Halberd Corp. EBITDA is −162.22 K USD, and current EBITDA margin is −16.37 K%. See more stats in Halberd Corp. financial statements.